Asia-Pacific IVF Service Market Expected to Reach $46216.8 Million by 2031 | CAGR of 17.1%

According to a new report published by Allied Market Research, titled, “Asia-Pacific IVF Service Market by Cycle type, and End User: Opportunity Analysis and Industry Forecast, 2022–2031", the Asia-Pacific IVF service market size was valued at $9373.2 Million in 2021 and is projected to reach $46216.8 Million by 2031, registering a CAGR of 17.1% from 2022 to 2031.

In-vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into uterus. IVF is one of the widely used treatments, which assist people with infertility problems including couples, single mothers, and the LGBT community.

Factors that drive the growth of the Asia-Pacific IVF service market include rise in number of product launches and product approvals and rise in gamete donation owing to the inability of couples to produce gametes and increase in same sex marriages. Moreover, rise in sperm donation has considerably increased in Asia-Pacific, owing to increase in financial benefits to the donors. Thus, rise in gamete donations is expected to drive the growth of the Asia-Pacific IVF services market in the future. Also, gamete donations are not available or banned in some countries such as Italy, Egypt, and Morocco, due to which patients prefer to travel to Asia for further infertility treatments; thereby, driving the growth of IVF services in the region.

In addition, the market for Asia-Pacific IVF service is expected to develop due to increase in fertility clinics and the number of experts performing IVF procedures. Also, rise in disposable income among the population of developing nations and increase in R&D activities, both contribute to the market's expansion.

However, the Asia-Pacific IVF service market growth is restricted by complications associated with IVF treatment and low awareness level for IVF in some underdeveloped regions. Awareness about fertility-related problems in men and women may be due to genetic, physical disorders or environmental factors need to be addressed.

Moreover, low awareness about availability of IVF processes, advantages of IVF and cost of IVF process will negatively impact the market growth. However, some organizations are taking initiatives to spread the awareness regarding IVF process. For instance, Gurugram Hospital in March 2020 launched a Specialized Infertility Program and Awareness Campaign to make infertile couples aware about medical advancement by sharing IVF success stories with the audience on how the availability of modern and advanced technology is helping couples embracing parenthood.

By cycle type, the market is segmented into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor) and donor eggs IVF cycle. The fresh IVF cycles (non-donor) segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in prevalence of infertility among female population and increase in the number of product launch for IVF technology.

By end user, the market is divided into fertility centers, hospital, surgical centers and clinical research institutes. The fertility clinics segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to increase in the number of fertility clinics and rise in the expenditure by government to develop healthcare infrastructure.

Key Findings Of Study

• By cycle type, the fresh IVF cycles (non-donor) the segment was the highest contributor to the market in 2021.
• By end user, the fertility clinics segment dominated the market in 2021, and is expected to continue this trend during the forecast period.